A recent poll given to doctors showed that while they admit having some effect on healthcare costs, they felt the majority of health price control remained in the hands of lawyers, health insurance companies, hospitals, pharmaceutical companies, and patients.
A recent poll given to doctors showed that while they admit having some effect on healthcare costs, they felt the majority of health price control remained in the hands of lawyers, health insurance companies, hospitals, pharmaceutical companies, and patients.
Researchers at the Mayo Clinic found that out of 2,500 doctors, 59% believed they had some responsibility in holding down healthcare costs, while only 36% voiced having a major role. More than half of those polled physicians agreed that the 5 other stakeholder groups carried a “major responsibility.”
“What physicians are trying to tell us is that they don’t see themselves as necessarily any more responsible for healthcare costs than all of those stakeholders,” said Dr Jon Tilburt, associate professor at the Mayo Clinic and study author. “They see themselves as a contributor, not a main contributor.”
The researchers argue that it may be necessary to phase in more aggressive financial changes. With monitoring, they could ensure the integrity of clinical relationships would not be infringed upon.
"This is a denial of responsibility," stated Ezekiel Emanuel, MD, PhD, and Andrew Steinmetz, both from the University of Pennsylvania in Philadelphia. "Of course, physicians do not want to be blamed for the country's major problem. But can they really be both the captain of the healthcare ship and cede responsibility for cost control to almost everyone else?"
Dr Emanuel added that physicians must accept and take responsibility for controlling healthcare costs. With 85% of respondents agreeing that "trying to contain costs is the responsibility of every physician," the group’s findings suggest that it might take a larger policy reform in physician payment models to successfully encourage value-based, quality-driven performance.
“[Physicians] are most enthusiastic about those cost-containing strategies that improve the quality of care, that bring evidence to the bedside, and that are a clear win-win for the doctor, the patient, and the health system," Tilburt said in a recent interview. "They get more nervous when their bottom line is at stake."
Around the Web
Study: Doctors Look To Others To Curb Health Costs
Study: Doctors Look To Others To Play Biggest Role In Curbing Health Costs [Kaiser Health News]
Docs Point to Others to Cut Health Costs [MedPage Today]
Potential Spillover Effects on Traditional Medicare When Physicians Bear Medicare Advantage Risk
February 26th 2025Medicare beneficiaries treated by physicians with high levels of Medicare Advantage risk exposure had higher care quality and efficiency outcomes compared with those treated by other physicians.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Balancing Cost and Quality in Oncology: A Value-Based Care Perspective
January 30th 2025Travis Brewer, vice president of payer and public health strategy/relations at Texas Oncology, shared that value-based oncology care can achieve both cost efficiency and high-quality outcomes through integrated multidisciplinary teams, flexible payment models, and targeted treatment approaches.
Read More
Balancing Innovation and Equity in Oncology Value-Based Care: Panel Discussions
January 27th 2025Discussions also delved into the complexities of value-based oncology care, the growing role of real-world data, and strategies to improve access to care in hematology. Across all sessions, a common theme emerged: the need to balance innovation with patient-centered, equitable, and sustainable care models.
Read More